Angenot L: De l'existence en afrique Centrale d'un poison de fleche curarisant, issu du Strychnos usambarensis Gilg. Annales Pharmaceutiques Fran,caises 29: 353-364, 1971.
Angenot L, Dubois M, Ginion Ch, van Dorsser W, Dresse A: Chemical structure and pharmacological (curarizing) properties of various indole alkaloids extracted from african Strychnos. Arch Int Pharmacodyn Ther 275: 246-258, 1975.
Dideberg O, Dupont L and Angenot L: Determination de la structure cristalline et de la configuration absolue d'un dérivé de l'usambarensine. Acta Cryst B31: 1571-1575, 1975.
Quetin-Leclercq J, Dupont L, Wright CW, Phillipson JD, Warhurst DC and Angenot L: Modelisation moleculaire de l'usambarensine, de la tubulosine et de l'emetine, alcaloides cytotoxiques et antiamibiens. J Pharm Belg 46: 85-92, 1991.
Wright CW, Bray DH, O'Neill MJ, Warhurst DC, Phillipson JD, Quetin-Leclercq J and Angenot L: Antimæbic and antiplasmodial activities of alkaloids isolated from Strychnos usambarensis Planta Med 57: 337-340, 1991.
Wright CW, Allen D, Cai Y, Chen Z, Phillipson JD, Kirby GC, Warhurst DC, Tits M and Angenot L: Selective antiprotozoal activity of some Strychnos alkaloids. Phytother Res 8: 149-152, 1994.
Frederich M, Tits M, Hayette M-P, Brandt V, Penelle J, DeMol P, Llabres G and Angenot L: 10'-Hydroxyusambarensine, a new antimalarial bisindole alkaloid from the roots of Strychnos usambarensis. J Natl Prod 62: 619-621, 1999.
Bonjean K, De Pauw-Gillet MC, Quetin-Leclercq J, Angenot L and Bassleer R: In vitro cytotoxic activity of two potential anticancer drugs isolated from Strychnos: Strychnopentamine and usambarensine. Anticancer Res 16: 1129-1138, 1996.
Leclercq J, De Pauw-Gillet MC, Bassleer R and Angenot L: Screening of cytotoxic activities of Strychnos alkaloids. J. Ethnopharmacolf 15: 305-316, 1986.
Bonjean K, De Pauw-Gillet MC, Defresne MP, Colson P, Houssier C, Dassonneville L, Bailly C, Greimers R, Wright C, Quetin-Leclerccj J, Tits M and Angenot, L: The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells. Biochemistry 37: 5136-5146, 1998.
Dassonneville L, Bonjean K, De Pauw-Gillet MC, Colson P, Houssier C, Quetin-Leclercq J, Angenot L and Bailly C: Stimulation of topoisomerase II-mediated DNA cleavage by three DNA- intercalating plant alkaloids. Cryptolepine, matadine and serpentine. Biochemistry 38: 7719-7726, 1999.
McGhee JD and Von Hippel PH: Theoretical aspects of DNA-protein interaction: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice. Journal of Molecular Biology 86: 469-489, 1974.
Houssier C and O'Konski CT: Electro-optical instrumentation systems with their data acquisiton and treatment. In: Molecular Electro-Optics (Krause S, ed.) New York: Plenum Publishing Corporation, 1981, pp309-339.
Colson P, Bailly C and Houssier C: Electric linear dichroism as a new tool to study sequence preference in drug binding to DNA. Biophys Chem 58: 125-140, 1996.
Cory AH, Owen TC, Barltrop JA and Cory JG: Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays. Cancer Commun 3: 207-212, 1991.
Papanicolaou GN: A new procedure for staining vaginal smears. Science 95: 438-439.
Caprasse M and Houssier C: Do planar alkaloids from Strychnos usambarensis intercalate into the DNA helix? Biochimie 65: 157-167, 1983.
Compton MM: A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome. Cancer Metastasis Rev 11: 105-119, 1992.
Bossy-Wetzel E, Newmeyer DD, Green DR: Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 17: 37-49, 1998.
